Xiya Reagent:Epigenomics is a molecular diagnostics company deve

Epigenomics is a molecular diagnostics company developing and commercializing a pipeline of proprietary products for cancer. The Company's products enable doctors to diagnose cancer earlier and more accurately， leading to improved outcomes for patients. Epigenomics' lead product， Epi proColon， is a blood-based test for the early detection of colorectal cancer， which is currently marketed in Europe， and has received approval by the Chinese Food and Drug Administration for China and is under regulatory review by the U.S. Food and Drug Administration (FDA). Additionally， the Company markets its tissue assay for use in lung cancer diagnosis， Epi proLung？， in Europe. The Company's technology and products have been validated through multiple partnerships with leading global diagnostic companies and testing laboratories. Epigenomics is an international company with operations in Europe and the U.S.A.

About BioChain

BioChain is a manufacturer of Life Sciences tools and the pioneer of molecular genetics diagnostics in the US and China. It is also the owner and operator of an independent reference laboratory， equivalent of a CLIA lab， in China - Beijing BioChain Medical Laboratory (BBML). BBML is unique in that it focuses on the application of molecular diagnostics technologies and products. BBML is located in the economic development zone of Beijing， China. Through BBML， BioChain is committed to the application of the cutting edge "omics" technologies in the areas of reproductive health and cancer diagnosis. BBML offers comprehensive services to its customers in China with a list of cellular and molecular test menus based on diverse technologies appropriate to each stage and type of disease.· 以上资料由西亚试剂：http://www.xiyashiji.com/ 提供此产品的详细信息如密度,含量,分子式,分子量等均可在西亚官网查询